Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07519577) titled 'A Study of CM512 in Patients With Chronic Rhinosinusitis With Nasal Polyposis (NEZHA-2)' on April 2.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Keymed Biosciences Co.Ltd
Condition:
Chronic Rhinosinusitis With Nasal Polyposis
Intervention:
Biological: CM512
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollment: May 31, 2026
Target Sample Size: 120
Countries of Recruitment:
China
To know more, visit https://clinicaltrials.gov/study/NCT07519577
Publis...